Did you mean 60 4,5 1?
Displaying drugs 10101 - 10125 of 11962 in total
Olmutinib
Olmutinib is an orally active epidermal growth factor receptor inhibitor used in the treatment of T790M mutation positive non-small cell lung cancer. It is available under the brand name Olita made by Hanmi Pharmaceuticals . Olmutinib was developed by Hanmi Pharmaceuticals and Boehringer Ingelheim. Olmutinib recieved breakthrough therapy designation in...
Investigational
Matched Iupac: … N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
S-3APG
S-3APG (S-3-[3-amino-phthalimido]-glutarimide) is a derivative of thalidomide with dual activity against B-cell neoplasias.
Investigational
Matched Iupac: … 4-amino-2-(2,6-dioxopiperidin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Medetomidine
Medetomidine is a synthetic compound used as a surgical anesthetic and analgesic. It is normally found as its hydrochloride salt, medetomidine hydrochloride. Medetomidine is an intravenously available alpha-2 adrenergic agonist. The drug has been developed by Orion Pharma. In the United States, it is currently approved for its veterinary use...
Experimental
Vet approved
Matched Synonyms: … (±)-4-(α,2,3-trimethylbenzyl)imidazole …
Matched Iupac: … 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole …
Matched Salts cas: … 86347-15-1 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Iupac: … 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole …
Matched Salts cas: … 86347-15-1 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Osivelotor
Investigational
Matched Synonyms: … (S)-2-hydroxy-6-((4-(2-(2-hydroxyethyl)nicotinoyl)morpholin- 3-yl)methoxy)benzaldehyde …
Matched Iupac: … 2-hydroxy-6-{[(3S)-4-[2-(2-hydroxyethyl)pyridine-3-carbonyl]morpholin-3-yl]methoxy}benzaldehyde …
Matched Iupac: … 2-hydroxy-6-{[(3S)-4-[2-(2-hydroxyethyl)pyridine-3-carbonyl]morpholin-3-yl]methoxy}benzaldehyde …
7-Methyl-7,8-dihydroguanosine 5'-(dihydrogen phosphate)
Experimental
Matched Name: … 7-Methyl-7,8-dihydroguanosine 5'-(dihydrogen phosphate) …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-6,7,8,9-tetrahydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl] …
Matched Iupac: … {[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-6,7,8,9-tetrahydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl] …
N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE
Experimental
Matched Name: … N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE …
Matched Iupac: … (2S)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-2-methylpentanedioic …
Matched Iupac: … (2S)-2-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-2-methylpentanedioic …
Mesoheme
The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins.
Experimental
Matched Iupac: … ^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-3,5,7,9,11,13,15,17,19,21(24)-decaene ... 4,20-bis(2-carboxyethyl)-9,14-diethenyl-5,10,15,19-tetramethyl-2,22,23,25-tetraaza-1-ferraoctacyclo[11.9.1.1 …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds with 4 or More Rings …
Matched Categories: … Heterocyclic Compounds, 1-Ring ... Heterocyclic Compounds with 4 or More Rings …
Darapladib
Investigational
Matched Iupac: … -1-yl)-N-{[4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl]methyl}acetamide ... N-[2-(diethylamino)ethyl]-2-(2-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxo-1H,4H,5H,6H,7H-cyclopenta[d]pyrimidin …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Cerlapirdine
Cerlapirdine has been investigated for the treatment of Alzheimer Disease.
Investigational
Matched Iupac: … dimethyl(3-{[3-(naphthalene-1-sulfonyl)-1H-indazol-5-yl]oxy}propyl)amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Naftidrofuryl
Experimental
Matched Iupac: … 2-(diethylamino)ethyl 3-(naphthalen-1-yl)-2-[(oxolan-2-yl)methyl]propanoate …
Matched Salts cas: … 3200-06-4 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Salts cas: … 3200-06-4 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Niridazole
Experimental
Matched Iupac: … 1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline
Experimental
Matched Name: … N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline …
Matched Iupac: … N-benzyl-4-{[(2R)-pyrrolidin-2-yl]methoxy}aniline …
Matched Iupac: … N-benzyl-4-{[(2R)-pyrrolidin-2-yl]methoxy}aniline …
Pantothenoylaminoethenethiol
Experimental
L-threonic acid
Experimental
Valiloxibic acid
Investigational
Matched Synonyms: … 4-((l-valyl)oxy)butanoic acid …
Matched Iupac: … 4-{[(2S)-2-amino-3-methylbutanoyl]oxy}butanoic acid …
Matched Iupac: … 4-{[(2S)-2-amino-3-methylbutanoyl]oxy}butanoic acid …
D-3082-L
D-3082-L is one of the components of the human papilloma virus (HPV) type 16 E6/E7 synthetic long peptide (SLP) vaccine ISA101b.
Investigational
3,4-Methylenedioxy-N-isopropylamphetamine
MDI-P has demonstrated potent anti-HIV activity. MDI-P has been shown to be effective in killing HIV in cell culture. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). MDI-P is also a potential therapeutic agent for the treatment of the symptoms of cystic fibrosis ("CF").
Investigational
Matched Iupac: … [1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](propan-2-yl)amine …
2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID
Experimental
Matched Name: … 2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID …
Matched Iupac: … 2-[2-(4-chlorophenoxy)acetamido]benzoic acid …
Matched Iupac: … 2-[2-(4-chlorophenoxy)acetamido]benzoic acid …
4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE
Experimental
Matched Name: … 4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE …
Matched Iupac: … 4-methanesulfonylbenzene-1-carboximidamide …
Matched Iupac: … 4-methanesulfonylbenzene-1-carboximidamide …
Pegsunercept
Pegsunercept is used for treating rheumatoid arthritis. Phase II clinical trials were completed in January 2010.
Investigational
5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid
Experimental
Matched Name: … 5-Hydroxyamino-3-Methyl-Pyrrolidine-2-Carboxylic Acid …
Matched Iupac: … (2R,3R,5R)-5-(hydroxyamino)-3-methylpyrrolidine-2-carboxylic acid …
Matched Iupac: … (2R,3R,5R)-5-(hydroxyamino)-3-methylpyrrolidine-2-carboxylic acid …
Inolimomab
Inolimomab is under investigation as an agent to treat steroid-resistant graft vs host disease. It has thus far offered similar efficacy to other monoclonal antibody options, though it may carry a higher risk of infections.
Investigational
Quilizumab
Quilizumab is under investigation in clinical trial NCT01160861 (A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis).
Investigational
Sofalcone
Sofalcone is a mucosal protective agent that has been reported to inhibit growth of Helicobacter pylori. on adherence, production of vacuolating toxin (VT), and induction of interleukin-8 (IL-8) secretion by H. pylori.
Investigational
Matched Iupac: … 2-{5-[(3-methylbut-2-en-1-yl)oxy]-2-[(2E)-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}prop-2-enoyl]phenoxy …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Displaying drugs 10101 - 10125 of 11962 in total